Company Profile
Legend Biotech Corporation Stock Price, News & Analysis
- Ticker:
- LEGN
- Exchange:
- NASDAQ
- Sector:
- CAR-T Therapy, TCR-T Therapy, Antibody Drugs, ADCs, Biopharma
- Location:
- China with major global operations and listed in the U
Stock performance
19.28 USD (+1.21%)
Close
Last updated: August 6, 2026
6.74B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, LEGN closed up 1.21% at $19.28. No new same-company headline was identified in the current news window.
Company overview
Global Cell Therapy Company
Legend Biotech develops and commercializes cell therapies for cancer and other serious diseases.
CARVYKTI
CARVYKTI, or ciltacabtagene autoleucel, is a one-time BCMA-directed CAR T-cell therapy for multiple myeloma developed and commercialized with Johnson & Johnson.
Global Manufacturing and Access
Legend supports CARVYKTI across 18 markets through expanding manufacturing capacity, treatment-center certification, and partner-led commercialization.
CARVYKTI Clinical Expansion
The cilta-cel franchise is being developed across earlier lines of multiple myeloma treatment to broaden access beyond heavily pretreated disease.
Earlier Cell Therapy Pipeline
The company is advancing additional cell therapies beyond BCMA, including programs for hematologic malignancies and solid tumors.
Future catalysts
Legend Biotech’s catalysts are Carvykti sales growth, label-expansion opportunities, and further commercial execution in multiple myeloma. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
Source: Legend Biotech Corporation
- 02
Legend Biotech Announces CEO Transition
Source: Legend Biotech Corporation
- 03
Legend Biotech Corporation Announces Pricing of Public Offering
Source: Legend Biotech Corporation
- 04
Legend Biotech Corporation Announces Proposed Public Offering
Source: Legend Biotech Corporation
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Legend Biotech Corporation (LEGN)?
Legend Biotech Corporation (LEGN) most recently closed at 19.28 USD, a +1.21% move versus the previous session.
What is the market cap of Legend Biotech Corporation (LEGN)?
Legend Biotech Corporation currently has a market capitalization of 6.74B USD on BioPharmSignal.
What does Legend Biotech Corporation do?
Global Cell Therapy Company Legend Biotech develops and commercializes cell therapies for cancer and other serious diseases. CARVYKTI CARVYKTI, or ciltacabtagene autoleucel, is a one-time BCMA-directed CAR T-cell therapy for multiple myeloma developed and commercialized with Johnson & Johnson. Global Manufacturing and Access Legend supports CARVYKTI across...
On which exchange is LEGN stock listed?
Legend Biotech Corporation (LEGN) is associated with NASDAQ, China with major global operations and listed in the U, CAR-T Therapy, TCR-T Therapy, Antibody Drugs, ADCs, Biopharma.
What is Global?
Global Cell Therapy Company Legend Biotech develops and commercializes cell therapies for cancer and other serious diseases.
Which conditions is Legend Biotech Corporation targeting with Global?
Legend Biotech Corporation is associated with cancer therapeutics based on its company overview and current catalyst commentary.
How does Legend Biotech Corporation describe recent progress with Global?
Legend Biotech’s catalysts are Carvykti sales growth, label-expansion opportunities, and further commercial execution in multiple myeloma. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers...
What is Cell?
Global Cell Therapy Company Legend Biotech develops and commercializes cell therapies for cancer and other serious diseases.